INBRIJA is inhaled levodopa designed for use as needed when Parkinson's symptoms start to return. The return of symptoms is referred to as an "OFF episode," or an "OFF period."
In a clinical study, INBRIJA began to improve motor symptoms in as soon as 10 minutes and significantly improved them by 30 minutes. Individual results may vary.
Nobody knows your OFF periods better than you. Together, you and your doctor can set specific goals for managing your OFF periods.
Talk to your doctor about what you're going through. Share as much as you can. Use It Starts With You, a doctor discussion guide, to help you make the most of every minute, every time you see your doctor. Ask if INBRIJA may be right for you.
Before using INBRIJA, tell your healthcare provider about all your medical conditions, including:
- asthma, chronic obstructive pulmonary disease (COPD), or any chronic lung disease
- daytime sleepiness from a sleep disorder or if you get drowsy/sleepy without warning or take a medicine that increases sleepiness such as sleep medicines, antidepressants, or antipsychotics
- dizziness, nausea, sweating, or fainting when standing from sitting/lying down
- history of abnormal movement (dyskinesia)
- mental health problems such as hallucinations or psychosis
- uncontrollable urges (for example, gambling, increased sexual urges, intense urges to spend money, or binge eating)
- pregnancy or plans to become pregnant. It is not known if INBRIJA will harm an unborn baby.
- breastfeeding or plans to breastfeed. Levodopa (the medicine in INBRIJA) can pass into breastmilk and it is unknown if it can harm the baby.
Please see below for additional Important Safety Information.